Ngo, Belle
Liebschutz, Jane M.
Cheng, Debbie M.
Colasanti, Jonathan A.
Merlin, Jessica S.
Armstrong, Wendy S.
Forman, Leah S.
Lira, Marlene C.
Samet, Jeffrey H.
del Rio, Carlos
Tsui, Judith I. http://orcid.org/0000-0003-0877-5399
Funding for this research was provided by:
National Institute on Drug Abuse (R01DA037768)
Center for AIDS Research, Emory University (P30AI050409)
Providence/Boston Center for AIDS Research (P30AI042853)
Article History
Received: 14 November 2019
Accepted: 5 March 2021
First Online: 22 March 2021
Declarations
:
: This study was granted ethics approval by the institutional review boards of Boston University Medical Campus and Emory University. The patient cohort was approved by the IRBs at Boston University Medical Campus (H-33343) and Emory University (CR001-IRB00088340), and by the Grady Research Oversight Committee (000–88340). All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committees and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. <b>I</b>nformed written consent was obtained from all individual participants included in the study.
: Not applicable.
: Dr. Debbie Cheng serves on Data Safety and Monitoring Boards for Janssen. The remaining authors have no competing interests to declare.